Dr Florian Wernig
Dr Florian Wernig is a Consultant Endocrinologist at Imperial College Healthcare NHS Trust and a Honorary Clinical Senior Lecturer at Imperial College. Dr Wernig has a strong basis in research as well as training from top London institutions. He completed his MD in molecular endocrinology at the University of Innsbruck and carried out further research at the Austrian Academy of Sciences and at St George's University of London.
Type 1 diabetes treatment
Type 1 diabetes is a lifelong condition that can significantly affect your health and well-being. The London Clinic provides bespoke treatment plans.
6 consultants available
Dr Florian Wernig is a leading consultant endocrinologist based at Imperial College Healthcare NHS Trust and a Honorary Clinical Senior Lecturer at Imperial College London. Dr Wernig has extensive knowledge in all aspects of endocrinology, however, he has a particular interest in pituitary disease, adrenal disorders, neuroendocrine tumours, thyroid disorders and thyroid cancer.
Dr Wernig has a strong basis in research and is principle investigator for several international multicentre clinical trials. He is a fellow of the Royal College of Physicians and a member of the Endocrine Society, the British Society and the European Society for Endocrinology.
- Consultant Endocrinologist
Imperial College Healthcare NHS Trust
- Honorary Clinical Senior Lecturer
Imperial College London
- Year qualified 2000
- University of Innsbruck
- Adrenal gland disorders
- Calcium disorders/ Hyperparathyroidism
- Polycystic ovarian syndrome (PCOS)
- Neuroendocrine tumours
- Thyroid cancer
Authors: Hessa Boharoon, James Tomlinson, Clara Limback-Stanic, Anastasia Gontsorova, Niamh Martin, Emma Hatfield, Karim Meeran, Ramesh Nair, Nigel Mendoza, Jeremy Levy, Steve McAdoo, Charles Pusey, Florian Wernig
Publication year: 2020
Published by: Journal of the Endocrine Society
A rare cause of severe Cushing's syndrome
Zaman S, Patel B, Glynne P, Vanderpump M, Alsafi A, Khan S, Flora R, Palazzo F, Wernig F.Endocrinol Diabetes Metab Case Rep. 2020 Mar 13;2020:20-0011. doi: 10.1530/EDM-20-0011. Online ahead of print.PMID: 32168466 Free PMC article.
Antigen-Specific Immunotherapy with Thyrotropin Receptor Peptides in Graves' Hyperthyroidism: A Phase I Study
Pearce SHS, Dayan C, Wraith DC, Barrell K, Olive N, Jansson L, Walker-Smith T, Carnegie C, Martin KF, Boelaert K, Gilbert J, Higham CE, Muller I, Murray RD, Perros P, Razvi S, Vaidya B, Wernig F, Kahaly GJ.Thyroid. 2019 Jul;29(7):1003-1011. doi: 10.1089/thy.2019.0036. Epub 2019 Jun 13.PMID: 31194638 Free PMC article. Clinical Trial.